S Selvaraj Naicker

Title: S Selvaraj Naicker: Innovator in Immunoassay Technology

Introduction

S Selvaraj Naicker is a notable inventor based in Edmonton, Canada, recognized for his contributions to the field of immunoassay technology. With a total of two patents to his name, Naicker has made significant advancements in the measurement of cyclosporine and its metabolites, which are crucial for therapeutic drug monitoring.

Latest Patents

Naicker's latest patents include an immunoassay method for measuring cyclosporine and its metabolites. This invention focuses on the production of polyclonal and monoclonal antibodies targeting specific regions of cyclosporine (CSA) and its derivatives. The antibodies developed through this method are particularly useful for creating immunoassays for therapeutic drug monitoring (TDM). These TDM kits may consist of various combinations of polyclonal and monoclonal antibodies, enabling precise monitoring of cyclosporine levels in patients. Additionally, Naicker's work involves the preparation of cyclosporine or CSA metabolite conjugate immunogens for immunizing host animals, which leads to the production of antibodies that can distinguish between the parent molecule, active metabolites, and inactive metabolites.

Career Highlights

Throughout his career, Naicker has worked with prominent companies such as Isotechnika Inc. and Isodiagnostika Inc. His expertise in immunoassay technology has positioned him as a key figure in the development of innovative solutions for drug monitoring.

Collaborations

Naicker has collaborated with notable professionals in his field, including Randall W Yatscoff and Andrew J Malcolm. These collaborations have further enhanced his research and development efforts in immunoassay technology.

Conclusion

S Selvaraj Naicker's contributions to immunoassay technology have significantly impacted therapeutic drug monitoring practices. His innovative patents and collaborations reflect his dedication to advancing medical science and improving patient care.